XML 66 R10.htm IDEA: XBRL DOCUMENT
v3.19.3.a.u2

Inventories | 12 Months Ended
--- | ---
Dec. 31, 2019
Inventories |
Inventories | 4. Inventories ​ Inventories are comprised of unprocessed tissue, work-in-process, Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Avive Soft Tissue Membrane, Axoguard Nerve Cap, Acroval Neurosensory and Motor Testing System, Axotouch Two-Point Discriminator and supplies and are valued at the lower of cost (first-in, first-out) or net realizable value and consist of the following: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | December 31, |  | December 31, |
​ | ​ | 2019 | ​ | 2018 | ​
​ | ​ | ​ | ​ | ​ | ​
Finished goods | ​ | $ | 10,403 | ​ | $ | 9,194 | ​
Work in process | ​ |  | 730 | ​ |  | 454 | ​
Raw materials | ​ | ​ | 2,728 | ​ |  | 2,334 | ​
Inventories | ​ | $ | 13,861 | ​ | $ | 11,982 | ​
​ For the years ended December 31, 2019, 2018 and 2017, the Company had recorded a provision for inventory write-downs of $1,887, $1,343 and $1,438, respectively, primarily relating to product expiration.

X
- References No definition available. + Details
Name: | us-gaap_InventoryDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 330 -URI http://asc.fasb.org/topic&trid=2126998 + Details
Name: | us-gaap_InventoryDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration